【摘 要】
：
Aims Sorafenib, a new multi-kinase inhibitor; the incidence of hypertension with sorafenib has been reported vary substantially among clinical trials.Methods We searched multiple database investigate
【机 构】
：
Thoracic Surgery of Jiangxi province tumor hospital
【出 处】
：
第17届中国南方国际心血管病学术会议
论文部分内容阅读
Aims Sorafenib, a new multi-kinase inhibitor; the incidence of hypertension with sorafenib has been reported vary substantially among clinical trials.Methods We searched multiple database investigate the risk of sorafenib-induced hypertension in patients with cancer.
其他文献
Objective Toassess the efficacy and safety of complementary TCM treatment in patients with chronic heart failure (CHF).Method China National knowledge Infrastructure (CNKI,1979.01 ～2013.06), Chinese S
目的 系统评价芪参益气滴丸治疗慢性心力衰竭(CHF)的临床疗效.方法 计算机检索中国期刊全文数据库、万方数据库、读秀数据库自建库以来至2014年12月公开发表的与芪参益气滴丸有关的临床随机对照试验(RCT),并手工检索相关的杂志,纳入符合标准的随机对照试验(RCT),采用RevMan 5.3软件进行Meta分析.
Objective Recently, some studies reported that proteolysismediated muscular atrophy in myocardial cells may be related to the pathogenesis of Dilated cardiomyopathy (DCM).LIM domain 7 (LMO7) gene has
目的 为了观察研究饮用微小分子团水理疗高血压和冠心病的效果,看能否逆转和消除动脉粥样硬化,治愈高血压和冠心病?能否对生命健康产生出乎意料的影响?方法 我1990年因患高血压而研究医学,发明了离子水瓶,处理成经核磁共振半幅宽检测值55.82赫兹的微小分子团水供饮用,向缺水的器官细胞补水,因其富含4～6个水分子缔合的小簇团,直径≤1.7纳米,容易进入细胞膜2纳米水通道,逐渐修复细胞膜糖脂通道和闸门,使
目的 探讨经食管四维超声心动图技术在成人心脏病外科矫治术中的应用价值.方法 2014年5月-8月应用GE Vivid E9经食管四维超声心动图对55例成人心脏外科手术患者进行术中超声监测(转机前及复跳后),包括瓣膜病38例,梗阻性肥厚型心肌病6例,先心病5例,动脉瘤2例,心脏肿瘤4例.
Objective To assess the right venticular functions (RVFs)in patients with Acute Myocardial Infarction (AMI) by 2D speckle tracking imaging (STI)and study the impacts of AMI on RVFs.
目的 总结急性心肌梗塞(AMI)合并室间隔穿孔(VSR)冠状动脉造影(CAG)特点.方法 2001年9月至2015年1月,对人住我院的急性心肌梗塞合并室间隔穿孔102例患者进行回顾性研究,其中37例患者完成了CAG,对CAG结果进行分析.结果 37例完成CAG的患者中,男性19例,女性18例,年龄49～86岁,平均61.3±8.67岁.其中CAG显示:单支病变11例(29.74％),双支病变7例(
Background The purpose of the present study was to investigate the diagnostic value of three-dimensional speckle-tracking echocardiography (3D-STE) for estimating left ventricular filling pressure in
Background and objective To perform a meta-analysis of published clinical trials to determine relative risk (RR)and incidence of gastrointestinal events (anorexia, constipation, diarrhea, nausea and v
Aims Sorafenib, a new muhi-kinase inhibitor, the treatment-related mortality with sorafenib has been reported.Methods We searched multiple databases investigate the risk of treatment-related mortality